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Abstract
Background: Bacterial vaginosis (BV) – a syndrome characterised by a shift in vaginal flora – appears to be particularly common
in sub-Saharan Africa, but little is known of the pattern of vaginal flora associated with BV in Africa. We conducted a study aimed
at determining the prevalence of BV and patterns of BV-associated vaginal micro-flora among women with vaginal discharge
syndrome (VDS) in The Gambia, West Africa.
Methods: We enrolled 227 women with VDS from a large genito-urinary medicine clinic in Fajara, The Gambia. BV was
diagnosed by the Nugent's score and Amsel's clinical criteria. Vaginal swabs were collected for T vaginalis and vaginal flora
microscopy, and for Lactobacillus spp, aerobic organisms, Candida spp and BV-associated bacteria (Gardnerella vaginalis, anaerobic
bacteria, and Mycoplasma spp) cultures; and cervical swabs were collected for N gonorrhoeae culture and C trachomatis PCR. Sera
were tested for HIV-1 and HIV-2 antibodies. Sexual health history including details on sexual hygiene were obtained by
standardised questionnaire.
Results: BV prevalence was 47.6% by Nugent's score and 30.8% by Amsel's clinical criteria. Lactobacillus spp were isolated in
37.8% of women, and 70% of the isolates were hydrogen-peroxide (H202)-producing strains. Prevalence of BV-associated
bacteria were: G vaginalis 44.4%; Bacteroides 16.7%; Prevotella 15.2%; Peptostretococcus 1.5%; Mobiluncus 0%; other anaerobes 3.1%;
and Mycoplasma hominis 21.4%. BV was positively associated with isolation of G vaginalis (odds-ratio [OR] 19.42, 95%CI 7.91 –
47.6) and anaerobes (P = 0.001 [OR] could not be calculated), but not with M hominis. BV was negatively associated with
presence of Lactobacillus (OR 0.07, 95%CI 0.03 – 0.15), and H2O2-producing lactobacilli (OR 0.12, 95% CI 0.05 – 0.28). Presence
of H2O2-producing lactobacilli was associated with significantly lower prevalence of G vaginalis, anaerobes and C trachomatis. HIV
prevalence was 12.8%. Overall, there was no association between BV and HIV, and among micro-organisms associated with BV,
only Bacteroides spp. and Prevotella spp. were associated with HIV. BV or vaginal flora patterns were not associated with any of
the factors relating to sexual hygiene practices (vaginal douching, menstrual hygiene, female genital cutting).
Conclusion: In this population, BV prevalence was higher than in corresponding populations in industrialised countries, but the
pattern of vaginal micro-flora associated with BV was similar. BV or vaginal flora patterns were not associated with HIV nor with
any of the vaginal hygiene characteristics.
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Background
Bacterial vaginosis (BV) is a poly-microbial syndrome
characterised by a shift in vaginal flora from a predomi-
nant population of lactobacilli to their gradual or total
replacement with anaerobes such as Gardnerella vaginalis,
Prevotella, Bacteroides and Mobiluncus species (spp), and
with other bacteria including Mycoplasma and Ureaplasma
species [1]. BV is one of the most frequent conditions
encountered in sexually transmitted diseases (STD), geni-
tourinary medicine (GUM) or other reproductive health
clinics throughout the world. BV has been strongly associ-
ated with poor pregnancy outcomes such as preterm deliv-
ery of low-birth-weight infants [2] and several studies
have now established associations between BV and HIV
[3-5]. BV appears to be particularly common in sub-Saha-
ran Africa where several studies have reported high preva-
lence rates, ranging from 20–49% among women
presenting to STD clinics with vaginal discharge [6-8],
from 21–52% among pregnant women attending antena-
tal clinics [9-11], and from 37–51% in community-based
studies [3,12]. These are very much higher than the rates
reported from industrialised countries, 13% in GUM
clinic attenders in the UK [13], 11% in gynaecology clinic
attendees in London [14], and 15% to 30% in studies of
non-pregnant women in USA [15].
The reasons for these disparities are not entirely clear, but
may arise in part through the use of different case defini-
tions for BV, and because the pattern of vaginal micro-
flora associated with this condition may differ in different
populations. Earlier African studies have relied on the
Amsel's clinical definition of BV [16], whilst more recent
studies have adopted the microbiological Nugent's scor-
ing technique [17]. The latter method relies on the identi-
fication of categories of vaginal micro-flora based on
quantitative assessment of a vaginal Gram-stained smear.
The Nugent's method has been extensively validated in
industrialised countries where numerous vaginal flora
studies have been conducted [1], but little is known of the
pattern of vaginal micro-flora associated with BV in Africa.
The characterisation of vaginal micro-flora is an impor-
tant step in understanding the pattern of flora associated
with BV. This information may help investigate the signif-
icance of this condition in clinical pathology and for tar-
geting treatment. In particular, it is important to know
whether vaginal flora changes may enhance HIV acquisi-
tion as suggested [5], and to unravel some of the factors
that influence such changes, as these could be perhaps
modified. Behavioural factors such as vaginal douching or
menstrual hygiene practices have been suggested as
important factors that might influence vaginal flora com-
position [18], but little data is available from African
populations[19,20].
We have conducted a study aiming at determining the
prevalence of BV among women self-presenting with vag-
inal discharge at a GUM clinic in Fajara, The Gambia. We
report here on the vaginal micro-flora patterns and vagi-
nal hygiene practices found in these patients and associa-
tions with their HIV serostatus.
Methods
Study population and sample collection
This study was part of a WHO-sponsored evaluation of STI
syndromic management and of a novel rapid diagnostic
test for BV conducted at the GUM clinic of the Medical
Research Council (MRC) in Fajara, The Gambia. Study
details have been reported elsewhere [21]. Briefly, consec-
utive and consenting women aged 18 and over, attending
the MRC clinic with self-reported symptoms of vaginal
discharge and/or vaginal itching were included in the
study. Pregnant women were excluded because it was
anticipated that their vaginal flora might differ substan-
tially from that of other women attending the clinic. A
standardised questionnaire elicited socio-demographic
characteristics, reproductive and sexual health history
including vaginal douching and menstrual hygiene prac-
tices, and current STD symptoms. Women underwent
genital examination during which vaginal and cervical
swabs were collected. The first vaginal swab was used for
aerobic and anaerobic cultures; the second swab was used
for direct wet mount microscopy, detection of fishy amine
odour ("whiff" test) when mixed with 10% potassium
hydroxide (KOH) preparation, and vaginal pH determi-
nation (range 4.0–7.0); the third swab was rolled onto a
slide for Gram staining; two cervical swabs were collected
for Neisseria gonorrhoeae culture on modified Thayer-Mar-
tin media, and for Chlamydia trachomatis polymerase
chain reaction (PCR) testing using an in-house method
[22]. A blood sample was collected for HIV testing as rou-
tinely offered at the GUM clinic. Serological diagnosis of
HIV infection was done according to a strategy described
elsewhere [23]. In brief, sera were screened by the ICEHIV-
1.O.2 (Murex Diagnostics Ltd, Dartford, UK) and reactive
samples were retested by type-specific ELISAs: Well-
cozyme HIV recombinant -1 (Murex) for HIV-1, and ICE-
HIV-2 test (Murex) for HIV-2. Samples clearly positive in
one type were assigned the corresponding serological sta-
tus; samples positive in both ELISAs were further tested by
a synthetic peptide-based strip method, Pepti-Lav 1–2
(Sanofi Diagnostics Pasteur, Marne-La-Coquette, France).
Treatment was given to all women according to the Gam-
bian government syndromic management protocols cov-
ering all likely vaginal and cervical infections. This
included a single dose of 2.0 g of metronidazole to cover
Trichomonas vaginalis (TV) and BV. HIV-infected patients
were referred internally to our specialist clinic and man-
aged according to local standard guidelines.
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Microbiological methods for vaginal flora assessment
The wet preparations were examined microscopically for
the presence of motile TV, yeast cells, and 'clue cells'.
Vaginal smear slides were heat fixed, Gram-stained and
examined for vaginal flora categories using the Nugent's
method [17]. The method involves assigning a score
between 0 and 10 based on quantitative assessment of the
Gram-stain for three different bacterial morphotypes: (i)
large Gram-positive rods (indicative of Lactobacillus spp),
(ii) small Gram-negative or variable rods (indicative of
Gardnerella, Bacteroides and other anaerobic bacteria), and
(iii) curved, Gram-variable rods (indicative of Mobiluncus
spp). Scores between 0 and 3 represent 'normal vaginal
flora', between 4 and 6 'intermediate vaginal flora', and
scores between 7 and 10 are considered diagnostic for
'BV'.
Vaginal swabs were directly inoculated at the clinic onto:
(i) Columbia blood agar plates, which were incubated
aerobically at 37°C for 24 to 48 hours to isolate aerobic
bacteria, including lactobacilli; (ii) Columbia human
blood bi-layer agar plates, which were incubated micro-
aerophilically at 36°C and read after 48 to 72 hours for
Gardnerella vaginalis isolation; (iii) Columbia-base lake
horse blood kanamycin agar plates, which were incubated
anaerobically at 36°C for 48 to 72 hours to isolate anaer-
obic bacteria; (iv) Mycoplasma broths incubated for 48 hrs
then sub-cultured onto Mycoplasma agar, and incubated
micro-aerophilically for 48 to 72 hours; (v) Mann Rogosa
Sharpe (MRS) medium, which was used for the isolation
of Lactobacillus spp after incubation in CO2 at 37°C for 48
hours; and (vi) Sabouraud's agar plates, which were incu-
bated micro-aerophilically at 36°C 24 to 48 hour to iso-
late Candida spp.
Growth of bacterial isolates was graded as confluent
(heavy growth), semi-confluent (moderate pure to mixed
growth of bacteria with visible separate single colonies);
and scanty (occasional single isolated colonies).
Presumptive identification procedures
Lactobacilli and other aerobic flora
Lactobacilli were presumptively identified by their ability
to grow well on MRS, Gram stain microscopy and catalase
reaction. Isolates were further tested for their ability to
produce hydrogen peroxide (H2O2) using a 2,3 tetrame-
thyl benzedine method [24], and classified as positive
when they produced blue coloration. The level of H2O2
production was determined by visually grading the inten-
sity of the blue colour produced into low, moderate and
high categories.
Coliform spp were identified as Gram-negative lactose fer-
menting rods; Staphylococcus spp were identified by their
characteristic colony and Gram stain morphology, then
tested for coagulase production (slide test); Gram-positive
beta-haemolytic Streptococcus spp isolates were further
typed using a rapid latex test according to the manufac-
turer's instructions (Streptex, Murex Biotech Ltd, Darford
Kent, UK).
Candida spp were identified as colonies with typical yeast-
like morphology and by characteristic morphology on a
wet preparation examination (presence of budding cells
and/or pseudo-hyphae).
BV-associated bacteria
Gardnerella vaginalis was identified by beta-haemolytic
appearance of the colonies on human blood bilayer agar
plate but not on sheep blood agars, Gram stain morphol-
ogy (Gram-variable pleiomorphic coccobacilli mostly
forming clumps) and negative catalase and oxidase
reactions.
Suspected anaerobic isolates were sub-cultured onto
Columbia blood agar without antibiotics and incubated
in aerobic and anaerobic conditions. Strict anaerobes
were further identified by Gram staining and antibiotic
susceptibility to erythromycin, rifampicin, colistin, peni-
cillin, kanamycin and vancomycin (Oxoid Discs, Unip-
ath, Basinstoke, Hampshire UK). Gram-negative
anaerobic bacilli were tested and the isolates which grew
on bile medium and hydrolysed aesculin were identified
as Bacteroides spp. Isolates which failed to grow on bile or
hydrolyse aesculin were identified as Prevotella spp [25].
Mycoplasma spp were identified as typical "fried egg" colo-
nies and stained with Diene's stain. They were further pre-
sumptively identified as Mycoplasma hominis by colonial
appearance and staining characteristics with a permanent
diffused light blue periphery and a darkly blue centre [25].
Diagnosis of bacterial vaginosis
The gold standard microbiological definition of BV was a
score of 7–10 by the Nugent's method described above.
Amsel's clinical criteria were also used to make a clinical
diagnosis of BV, which included the presence of any three
of the following; (i) homogeneous grey adherent vaginal
discharge; (ii) vaginal fluid pH ≥ 4.6; (iii) release of fishy
amine odour when 10% potassium hydroxide (KOH)
solution was added to a sample of vaginal fluid (the
"whiff" test); and (iv) the presence of 'clue cells' represent-
ing over 20% of vaginal epithelial cells on wet-prep micro-
scopic examination [16].
Ten percent random quality control checks were carried
out on the microscopist by an experienced BV micro-
scopist, for Nugent's score and wet preparation readings
for 'clue cells'.
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Statistical methods
Frequency tables were produced to describe the preva-
lence of genital infections and of micro-flora isolates.
Bacteroides, Prevotella, Peptostreptococcus and other anaero-
bic isolates were grouped as 'anaerobes'. Chi-square tests
were used to examine the association between isolates
and BV diagnosis by Nugent's score and Amsel's clinical
criteria in univariate analyses. Logistic regression was used
to estimate the association between each isolate and diag-
nosis of BV by one method adjusted for (i.e. within cate-
gories of) BV diagnosis by the other method; and to test
whether the observed associations were different between
categories of the other method (i.e. testing for interac-
tion). Chi-square and Fisher's Exact (for small numbers)
tests were used to examine associations between categori-
cal variables such as: isolation of lactobacilli, particularly
H2O2-producing strains and G vaginalis, anaerobic iso-
lates, Mycoplasma hominis, as well as N gonorrhoeae, C tra-
chomatis, Candida spp or T vaginalis; HIV and each of the
vaginal flora micro-organisms mentioned above, and
with BV (Nugent's score 7–10); HIV and vaginal hygiene
variables; and between BV and vaginal hygiene variables.
Ethical issues
The study was approved by the Ethical Committees of the
MRC Gambia and the London School of Hygiene & Trop-
ical Medicine, and by the Ethics Review Board of the
World Health Organisation.
Results
Two hundred and thirty women were enrolled in the
study over a four-month period in 2000, but data of three
women were subsequently excluded because the women
had not reported any symptoms consistent with our case
definition of vaginal discharge syndrome. The denomina-
tors used in subsequent analyses vary slightly depending
on completeness of microbiological investigations.
The median age of the patients was 26 years (range 18–
50), 71% of women were married, and a majority of
women (84%) reported only one sexual partner in the last
three months. Antibiotic use prior to attending the clinic
was reported by 18% of patients.
Table 1: Vaginal flora isolates by Nugent's score among women presenting with vaginal discharge syndrome at the GUM clinic in 
Fajara, The Gambia
Total Samples Scanty Growth Semi-confluent growth Confluent growth P-value2
Nugent's score1 0–6 7–10 0–6 7–10 0–6 7–10 0–6 7–10
Isolate N N % (n) % (n) % (n) % (n) % (n) % (n)
Aerobic flora
Lactobacillus spp. 119 106 5.0 (6) 8.5 (9) 16.8 (20) 4.7 (5) 33.6 (40) 4.7 (5) <0.001
Coliform spp. 119 106 12.6 (15) 9.4 (10) 1.7 (2) 6.6 (7) 5.0 (6) 4.7 (5) 0.868
Staphylococcus spp. 119 105 24.4 (29) 37.1 (39) 9.24 (11) 4.8 (5) 0.8 (1) 0.9 (1) 0.217
Streptococcus spp. 119 105 13.4 (16) 15.2 (16) 11.8 (14) 12.4 (13) 13.4 (16) 10.9 (11) 1.000
Candida spp. 93 81 11.8 (11) 14.8 (12) 16.1 (15) 7.4 (6) 15.1 (14) 8.6 (7) 0.117
Microaerophilic flora
Gardnerella vaginalis 117 106 1.7 (2) 8.5 (9) 6.8 (8) 21.7 (23) 13.7 (16) 38.7 (41) <0.001
Anaerobic flora
Any anaerobic isolate3 34 32 1 (3) 2 (6) 2 (6) 9 (28) 3 (9) 6 (19) 0.0054
Bacteroides spp. 34 32 0 6.2 (2) 0 12.5 (4) 2.9 (1) 12.5 (4) 0.002
Prevotella spp. 34 32 2.9 (1) 0 2.9 (1) 9.4 (3) 2.9 (1) 12.5 (4) 0.180
Peptostreptococcus spp. 34 32 0 0 0 3.1 (1) 0 0 0.485
Other anaerobes5 34 32 0 0 1 (3) 2 (6) 1 (3) 0 0.801
Mobiluncus spp. 35 33 0 0 0 0 0 0 -
Mycoplasma hominis 115 105 0 0 2.6 (3) 0.9 (1) 14.8 (17) 24.8 (26) 0.142
Note: denominators vary according to the number of samples for which each test was conducted (see Results section).
1 Nugent's categories: score 0–6 = normal and intermediate flora; score 7–10 = BV.
2 From Fisher's Exact test.
3 Includes Bacteroides spp., Prevotella spp. and Peptostreptococcus spp. isolates and other anaerobes.
4 Anaerobic isolates were found in 21 samples out of 66; 5 women had more than 1 anaerobic isolate in which case the highest level of growth was 
used for the significance test.
5 Anaerobic Gram-negative rods, anaerobic Gram-positive or pigmented anaerobes.
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Clinical and aetiological findings
The prevalence of cervical infections was 6.3% (14/222)
for N gonorrhoeae and 15.0% (34/227) for C trachomatis. A
serum sample was obtained from 210 (93%) women and
27/210 (12.8%) of them were HIV infected (19 with HIV-
1, 7 with HIV-2, and 1 dually with HIV1 and HIV-2).
Using wet preparation microscopy, 10.1% (23/227) of the
women were positive for T vaginalis and 22.9% (52/227)
for yeast cells, with only two patients having a dual infec-
tion. 'Clue cells' were seen in 56.4% of the wet prepara-
tions but in only 23.1% of the Gram-stained smears. A
large majority of women (91.2%) had an elevated pH (≥
4.6). Overall, 30.8% (68/221) of women had a diagnosis
for BV according to the Amsel's criteria.
BV prevalence as determined by Nugent's score of 7–10
was 47.6% (108/227), 24.7% (56/227) women had
'intermediate flora' (score 4–6) and 27.7% (63/227) had
'normal flora' (score 0–3).
Vaginal flora cultures
Results of vaginal flora cultures for aerobic, micro-aer-
ophilic and anaerobic bacteria as well as cultures for Myc-
oplasma are shown in Table 1. Variations in the
denominators for the types of bacteria isolated were due
to cases of either contamination or growth failure. The
lower number of anaerobic cultures performed (n = 66)
was due to a breakdown in the supply of anaerobic Gas-
Packs. We defined two unidentified Gram-positive anaer-
obic isolates as 'Other' anaerobic isolates.
Gardnerella vaginalis, lactobacilli, streptococci and Myco-
plasma spp were present as confluent or semi-confluent
growth. Mobiluncus spp were not isolated. Staphylococcus
spp, and Coliforms spp were mostly present in scanty num-
Table 2: Association between vaginal micro-flora isolates and Nugent's vaginal flora categories and Amsel's diagnosis of bacterial 
vaginosis
Association with Nugent's vaginal flora categories Association with Amsel's diagnosis of BV
Isolate Nugent1 N2 %3 OR4 95% CI AOR5 95% CI Amsel6 N2 %3 OR4 95% CI AOR5 95% CI
Lactobacilli Normal flora 63 74.6 1 1
Interm. 54 35.2 0.18 0.08–0.41 0.18 0.08–0.41 Neg. 152 42.8 1 1
BV 102 16.7 0.07 0.03–0.15 0.06 0.03–0.15 Pos. 67 26.9 0.49 0.26–0.92 1.11 0.52–2.38
P7 <0.001 <0.001 P7 0.025 0.775
H2O2 - Lactobacilli Normal flora 49 49.0 1 1
Interm. 49 14.3 0.17 0.07–0.46 0.17 0.07–0.47 Neg. 134 24.6 1 1
BV 97 10.3 0.12 0.05–0.28 0.12 0.05–0.31 Pos. 61 13.1 0.46 0.20–1.07 0.94 0.36–2.49
P7 <0.001 <0.001 P7 0.067 0.909
G vaginalis Normal flora 61 11.5 1 1
Interm. 54 35.2 4.19 1.59–11.0 3.96 1.50–10.5 Neg. 150 35.3 1 1
BV 102 71.6 19.42 7.91–47.6 15.45 6.18–38.6 Pos. 67 68.7 4.01 2.17–7.42 2.21 1.10–4.44
P7 <0.001 <0.001 P7 <0.001 0.026
Anaerobic isolates8 Normal flora 21 0 1 1
Interm. 13 38.5 -9 -9 Neg. 43 18.6 1 1
BV 31 48.4 -9 -9 Pos. 22 54.6 5.25 1.68–16.38 4.5 1.24–16.37
P7 0.001 -10 P7 0.003 0.018
Mycoplasma hominis Normal flora 60 13.3 1 1
Interm. 53 22.6 1.90 0.71–5.09 1.85 0.69–4.97 Neg. 148 18.9 1 1
BV 102 25.5 2.22 0.93–5.29 2.00 0.80–4.96 Pos. 67 26.9 1.57 0.80–3.10 1.34 0.65–2.76
P7 0.184 0.282 P7 0.188 0.436
1 Nugent's categories: normal flora (score 0–3), intermediate flora (score 4–6), BV (score 7–10).
2 Number of specimens.
3 Percentage positive for the isolate.
4 Crude Odds Ratio.
5 Odds Ratio adjusting for the other method of diagnosing BV.
6 Amsel's diagnosis 'positive' [pos.] if at least 3 out of 4 criteria present (homogenous adherent discharge; pH ≥ 4.6; whiff test positive; clue cells on 
20% of epithelial cells); diagnosis is 'negative' [neg.] if <3 criteria present.
7 From X2 test for unadjusted analysis. From likelihood ratio test when adjusting for the other diagnostic method.
8 Anaerobic isolates comprise Prevotella spp, Bacteroides spp, Peptostreptococcus spp and other anaerobes.
9 Not possible to calculate OR relative to normal flora due to lack of anaerobic isolation in normal subjects.
10 Not possible to fit model due to lack of anaerobic isolation in normal subjects.
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bers. Bacteroides and Prevotella spp were present in semi-
confluent to confluent numbers.
Seventy percent (42/60) of lactobacilli tested were found
to be H2O2-producers, 12 at high level, 12 at intermediate
level, and 18 at low levels of H2O2 production. We could
not establish the ability of the remaining 25 lactobacilli
isolates to produce H2O2 because these isolates could not
be recovered from storage.
Staphylococcus spp were tested for coagulase production
and 20.5% (17/83) were identified as Staphylococcus
aureus. Serotype grouping was done for 61/86 Streptococ-
cus spp isolates which were successfully recovered and the
majority of these, 68.9% or 42 strains, were classified as
Group B, 2 as group C, 6 as group D, and 8 as group F.
Associations between bacterial vaginosis and vaginal flora
Patterns of micro-flora isolates according to BV diagnosis
by Nugent's score and Amsel's clinical criteria are summa-
rised in Table 2 and Figure 1. Isolation of lactobacilli and
H2O2-producing lactobacilli was negatively associated
with BV diagnosis by both Nugent's score (OR 0.07,
95%CI 0.03 – 0.15) and Amsel's criteria (OR 0.49, 95%CI
0.26 – 0.92). Within Amsel's diagnostic categories, the
Nugent's diagnosis of BV was still negatively associated
with lactobacilli (adjusted OR [AOR] 0.06, 95%CI 0.03 –
0.15). However, within Nugent's diagnostic categories,
Amsel's diagnosis of BV was not associated with lactoba-
cilli (AOR 1.11, 95%CI 0.52 – 2.38). G vaginalis and the
anaerobes were strongly associated with BV diagnosis by
both Nugent's score and Amsel's criteria. G vaginalis
remained significantly associated with BV diagnosis by
either method, within the diagnosis categories of the
other method. It was not possible to compare the preva-
lence of anaerobes across the three Nugent categories
within Amsel's diagnosis using a likelihood ratio test due
to the lack of anaerobic isolation in normal subjects. M
hominis was more common in women with BV by both
Nugent's and Amsel's criteria but the association was not
statistically significant. Coliform spp, staphylococci and
streptococci were not significantly associated with BV by
either Nugent's score or Amsel's criteria (data not shown).
The associations between the presence of lactobacilli,
including the presence of H2O2 producing lactobacilli
strains, and the isolation of other vaginal or cervical
organisms are shown in Table 3. There were significant 2
to 4 fold decreases in colonisation by G vaginalis or anaer-
obes in the presence of H2O2-producing lactobacilli (P <
0.001 and P = 0.016 respectively). M hominis isolation was
less prevalent in the presence of H2O2-producing lactoba-
cilli, but this was not statistically significant. Overall there
was no significant difference for Candida isolates (P =
0.108) but the lowest prevalence was observed when no
lactobacilli were isolated. Detection of C trachomatis was
significantly reduced (p = 0.024) in the presence of H2O2-
producing lactobacilli strains, whilst N gonorrhoeae was
isolated more frequently in the absence of lactobacilli,
although this was not statistically significant.
Associations between vaginal flora, vaginal hygiene 
practices and HIV
We found that only two anaerobic isolates, Bacteroides spp
and Prevotella spp, were significantly more common
among HIV positive women: 7/57 samples (12.3%) for
HIV negative women contained Bacteroides spp, compared
with 3/6 (50%) for HIV-positive women (P = 0.0046);
and 6/57 samples (10.5%) for HIV negative women
contained Prevotella spp, compared with 3/6 (50%) for
HIV positive women (P = 0.033). In overall crude analysis,
there was no association between BV (Nugent's score 7–
10) and HIV (all types): 12/110 (10.9%) women without
BV were HIV-infected vs. 15/100 (15.0%) women with BV
(table 4).
Details about vaginal hygiene practices were collected by
questionnaire: 37.8% (85/225) of women reported prac-
ticing vaginal washing before sex and 89.2% (199/223)
after sex, for a combined 90.2% of women (202/224)
practising some form of 'douching' before or after sex. Of
the women who douched, 57.6% (114/198) used water,
22.2% (44/198) used soap and water, 18.2% (36/198)
used a dry towel, and 2% (4/198) used commercial or
other cosmetic products. The source of water was 83% tap
water, and 17% water from a protected well. In crude uni-
variate analysis, there was no association between 'douch-
ing' and BV (Nugent's score 7–10) (Table 4), nor between
any of the individual vaginal hygiene variables and BV
(data not shown). The questionnaire also explored forms
of menstrual hygiene: 60.8% (118) of women reported
using traditional methods for sanitary protection (i.e.
reusable cloths), 34.8% (79) using sanitary pads, 4.0%
(9) tampons and 0.4% (1) other methods. Again, there
were no associations between these methods and
presence of BV (table 4). The majority of women (157/
227, 69.2%) were found circumcised on examination. The
dominant form of genital cutting in the Gambia belonged
to WHO classification Type II (i.e. removal of all/part of
the clitoris and labia minora) as reported previously [26].
Again no association with BV was noted (table 4). In over-
all crude univariate analysis, we did not find any associa-
tion between douching, menstrual hygiene, genital
cutting and HIV (table 4).
Discussion
The main objective of this study was to determine the
prevalence of BV and the pattern of vaginal micro-flora
among women with vaginal discharge syndrome in an
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Prevalence of microflora isolates by Amsel's clinical criteria diagnosis and Nugent's vaginal flora categoriesFigur  1
Prevalence of microflora isolates by Amsel's clinical criteria diagnosis and Nugent's vaginal flora categories
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African setting and to relate this to vaginal hygiene prac-
tices and HIV serostatus.
Using Nugent's score as the gold standard, a BV prevalence
of 47.6% was found in this population. This compares to
the range (20–49%) reported from other African popula-
tions attending STI clinics: 20–23% in Burkina Faso [7]
and Malawi [27], 37% in Tanzania [8] and 49% in Kenya
[6]. High prevalence of BV (21–29%) has also been
observed among pregnant women in Kenya and South
Africa [9,11,28], The reasons for higher BV rates in African
populations are not known. High BV rates have been
reported among African-American women [15], although
it has been argued that levels of education and other
Table 3: Association between lactobacilli and other genital micro-organisms
Genital micro-organisms Prevalence of genital micro-organism in those with:
No lactobacilli Non H2O2 producing lactobacilli H2O2 producing lactobacilli P-value1
n/N (%) n/N (%) n/N (%)
C trachomatis 21/140 (15.0) 4/18 (22.2) 1/42 (2.4) 0.024
N gonorrhoeae 12/138 (8.7) 0/17 (0) 1/42 (2.4) 0.303
Candida spp 34/110 (30.9) 6/14 (42.9) 16/32 (50.0) 0.108
T vaginalis 19/140 (13.6) 1/18 (5.6) 3/39 (7.1) 0.509
G vaginalis 78/140 (55.7) 5/18 (27.8) 9/40 (22.5) <0.001
Anaerobes 16/34 (47.1) 0/3 (0) 3/21 (14.3) 0.016
M hominis 33/137 (24.1) 5/17 (29.4) 5/40 (12.5) 0.214
1 From Fisher's Exact test because of small numbers in some categories.
Table 4: Prevalence of HIV and BV in symptomatic women, by douching, menstrual hygiene protection method and female genital 
cutting
Prevalence of BV (Nugent's score 7–10) Prevalence of HIV
n/N % P-value4 n/N % P-value4
Douching1
No 12/22 54.5 0.507 3/22 13.6 1.000
Yes 94/202 46.5 24/185 13.0
Menstrual hygiene protection method
Traditional2 70/138 50.7 0.323 17/129 13.2 1.000
Sanitary pads 34/79 43.0 9/71 12.7
Female genital cutting3
No 38/68 55.9 0.146 12/63 19.1 0.115
Yes 70/157 44.6 15/145 10.3
BV
No 12/110 10.9 0.414
Yes 15/100 15.0
1 Douching before and/or after sexual intercourse.
2 Old cloths washed and re-used as necessary.
3 Also known as "female circumcision"; in the Gambia, the type of female cutting belongs to WHO classification Type II, i.e. removal of all/part of the 
clitoris and labia minora.
4 P-values from Fisher's Exact Test.
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socio-economic factors were confounding these associa-
tions [15,29]. Lifestyle practices such as vaginal douching
have also been associated with an increased prevalence of
BV [15,18,19], although, the direction of causality is again
uncertain, since most studies have been of cross-sectional
nature and many potentially confounding factors such as
educational, socio-economical and behavioural factors
have not always been entirely controlled for. We did not
find any association between BV or vaginal micro-organ-
isms and vaginal hygiene practices such as douching
before or after sex, the nature of douching compounds
used, the source of the water, or with menstrual sanitary
protection. This finding perhaps owes to the fact that a
very large proportion of women reported these practices,
thus any relatively small association with BV would be
hard to find with our sample size. On the other hand,
additional possible explanations for the high prevalence
or incidence of BV in African populations have to be
sought – the role of hormonal factors should be explored.
An association between BV and HIV has been reported in
several studies [3,4,30], possibly influenced by vaginal
hygiene practices [18,20,31]. However, as in our study,
not all studies reporting on douching, BV and HIV have
found associations between these factors [19]. The rela-
tionship between HIV, risk for BV or other STIs is com-
plex, and could be contributed to by high risk sexual
behaviour. Our study population consisted only of
symptomatic women attending a GUM clinic, thus high-
risk behaviours may have blurred any possible associa-
tion. To our knowledge, this study is one of the first to
report on female genital cutting in relation to HIV and
vaginal flora in Africa. We did not find any significant
impact of circumcision on vaginal flora or HIV serostatus.
A comparison of vaginal micro-flora isolates with
Nugent's score showed significant positive associations
between a diagnosis of BV and the isolation of G vaginalis,
a significant positive association with anaerobes, and a
significant negative association with the presence of lacto-
bacilli. These findings are not surprising, since the method
employed for the Nugent's score is based on the observa-
tion of BV-associated bacterial morphotypes. Nonetheless
there have been no reports of vaginal micro flora culture
studies in African population aimed at exploring the pat-
terns of BV-associated flora. This study has demonstrated
similar vaginal bacterial isolates to those found in the
United States [32,33]. These studies found a strong associ-
ation between BV and the isolation of G vaginalis, anaero-
bic gram-negative rods belonging to the genera Prevotella,
Porphyromonas and Bacteroides, Peptostreptococcus spp, M
hominis, Ureaplasma urealyticum, and often Mobiluncus spp.
A lower concentration of facultative species of Lactobacillus
among women with BV in comparison to women with a
normal flora was noted in this study. Lactobacilli are
reported to play an important role in the maintenance of
normal vaginal flora [34,35] through the provision of
defence mechanisms against pathogenic organisms via
hydrogen peroxide (H202) production and the mainte-
nance of an acidic microenvironment generated by lactic
acid production. A low pH has been shown to have a
direct microbicidal and virucidal effect [36]. Hydrogen
peroxide, which is produced by some lactobacilli strains,
also has a direct antimicrobial effect. H2O2 can inhibit the
growth of Bacteroides, Gardnerella, Mobiluncus, Mycoplasma
and other vaginal organisms by acting directly on these
organisms using its toxic effect, or by reacting with halide
ions in the presence of vaginal peroxidase as part of the
H2O2-halide peroxidase antibacterial system. Lactobacilli
can also adhere onto vaginal epithelial cells [37] thus
blocking the attachment of any pathogenic BV-associated
bacteria onto these cells, Lactobacilli are known to pro-
duce biosurfactant, bacteriocins and coaggregation mole-
cules [38], all of which contribute to the maintenance of
a healthy vaginal micro-environment.
In our study, a large proportion of lactobacilli isolates
(70%) were H2O2 producers. These isolates were associ-
ated with a significantly lower prevalence of G vaginalis,
anaerobes and C trachomatis, with trends of lower preva-
lence of N gonorrhoeae and M hominis, suggesting a protec-
tive effect of vaginal/cervical colonisation conferred by
these lactobacilli strains. The absence of H202-producing
lactobacilli was not associated with growth of Candida
spp. This is different from the findings observed in a study
conducted by Hillier et al [35], in which significant asso-
ciations between H2O2 production and protection against
BV and other STI as well as protection against sympto-
matic candidiasis were reported.
In previous studies [39,40], M hominis and Ureaplasma ure-
alyticum have been associated with BV, although not in all
cases [41]. In our study, there appears to be some associa-
tion between M hominis and BV, defined either by
Nugent's score or Amsel's criteria, but these were not sta-
tistically significant. This observed difference may be due
to the different detection protocols employed by different
researchers.
Other bacteria that have been isolated in this study
included Staphylococcus spp (38.4%), Coliform spp
(20.0%)and Streptococcus spp (38.4%) but they were not
associated with any particular vaginal microflora. Most of
the staphylococci isolates were coagulase-negative, which
are perceived to be normal commensal organisms. Most
streptococci were found to belong to group B, an organ-
ism which can be highly pathogenic, particularly at time
of delivery when it has been associated with neonatal sep-
sis and premature delivery [42]. The high prevalence of
Group B streptococci seen in this study was similar to that
BMC Infectious Diseases 2005, 5:12 http://www.biomedcentral.com/1471-2334/5/12
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reported in previous work done in The Gambia [43]. The
latter study, however, failed to demonstrate any associa-
tion between isolation of Group B streptococci and dis-
ease manifestation in neonates. Thus, the high prevalence
of group B streptococci isolates reported in this study may
not pose any significant clinical problem in this setting.
Several logistical problems have arisen in the course of
this study, which may limit interpretation of the data on
vaginal flora patterns. First, Mobiluncus spp, were not iso-
lated despite observing Mobiluncus-like organisms in some
of the vaginal Gram-stained smears. This finding could be
attributed to a low prevalence of Mobiluncus in our popu-
lation, or to an inadequate isolation procedure, which
will warrant further investigation. Second, our adoption
of a 48-hours incubation period for broth- and agar- Myc-
oplasma culture procedures did not favour the isolation of
Ureaplasma urealyticum, as the latter is sensitive to the met-
abolic by-products generated during extended incubation
periods. This may have been partly responsible for the
lack of Ureaplasma isolation in this study. Finally, there
was a low-recovery rate for a significant number of stored
isolates. Optimum storage procedures are not easy to
maintain in tropical climates. These logistical problems
with fastidious organisms may explain why it is difficult
to attempt studies of vaginal flora in developing countries.
Another possible limitation of our study was the absence
of inclusion of women who did not complain of vaginal
discharge syndrome, which would have allowed a more
comprehensive description of patterns of vaginal flora in
symptomatic and symptomless women. Our study shows,
however, that the pattern of organisms cultured in BV in
this environment is similar to what has been reported in
corresponding populations in industrialised countries,
and therefore suggest that different vaginal flora patterns
are not the major explanation behind the higher preva-
lence of BV in Africa.
In most STI or GUM clinics in industrialised countries,
routine BV diagnosis is made using Nugent's score or
Amsel's clinical criteria. In resource-poor settings good
microscopy is not often available, and clinicians rely on
clinical judgement or may apply all or part of the Amsel's
clinical criteria. This study found there was an association
between Amsel's criteria and Nugent's score, a strong cor-
relation between Amsel's diagnosis and the presence of G
vaginalis and anaerobes, and a negative correlation with
the presence of lactobacilli. However, as shown in Figure
1, a large number of true BV cases (by Nugent's score)
were missed by the Amsel's method, limiting its utility as
a BV diagnostic method. The Amsel's method can be
highly subjective with regards the description of the dis-
charge and the olfactive component ('whiff' test); the wet
mount microscopy depends on the experience of the
microscopist and can represent a further subjective ele-
ment, particularly when performed under pressing clini-
cal conditions [1]. Despite regular supervision and the use
of the same clinician and microscopist throughout the
study (which insured internal consistency of our results),
the discrepancies we found between the Amsel's criteria
and the accepted gold standard diagnosis (Nugent's
method) in this study appear to preclude the use of this
method under routine clinical conditions in our setting.
Our study found that where Gram-staining led to a classi-
fication of 'intermediate flora' by Nugent's score, this was
reflected in the microbiological findings, which were
'intermediate' quantitatively and qualitatively between
'normal' and 'BV' categories (table 2 and figure 1) and dis-
tinct from them. This supports the validity of the classifi-
cation and could indicate that the 'intermediate' flora
precedes the development or follow the resolution of
frank BV. Longitudinal studies are required to elucidate
this phenomenon.
Conclusion
In this population, BV prevalence was higher than in cor-
responding populations in industrialised countries, but
the pattern of vaginal micro-flora associated with BV was
similar. BV or vaginal flora patterns were not associated
with HIV nor with any of the vaginal hygiene characteris-
tics. Further studies on the public health significance of BV
in this kind of setting are needed to determine future strat-
egies for intervention
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